Digital-commerce-in-pharmaceuticals: Difference between revisions
A public knowledge platform on B2B digital commerce
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
* McKinsey, 2023 [https://www.mckinsey.com/industries/life-sciences/our-insights/rewired-pharma-companies-will-win-in-the-digital-age Rewired pharma companies will win in the digital age] | * McKinsey, 2023 [https://www.mckinsey.com/industries/life-sciences/our-insights/rewired-pharma-companies-will-win-in-the-digital-age Rewired pharma companies will win in the digital age] | ||
* Econsultancy, 2024 [https://econsultancy.com/pharma-marketing-trends-seo/ Pharma marketing’s Damascene moment with content and SEO] | * Econsultancy, 2024 [https://econsultancy.com/pharma-marketing-trends-seo/ Pharma marketing’s Damascene moment with content and SEO] | ||
* McKinsey, 2022 [https://www.mckinsey.com/jp/en/our-insights/demystifying-the-omnichannel-commercial-model-for-pharma-companies-in-asia Demystifying the omnichannel commercial model for pharma companies in Asia] | |||
''<-[[Collections-update-roadmap | Back to collections roadmap]]'' | ''<-[[Collections-update-roadmap | Back to collections roadmap]]'' | ||
Revision as of 12:43, 22 March 2024
Articles for review
- McKinsey, 2023 Rewired pharma companies will win in the digital age
- Econsultancy, 2024 Pharma marketing’s Damascene moment with content and SEO
- McKinsey, 2022 Demystifying the omnichannel commercial model for pharma companies in Asia
<- Back to collections roadmap